We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesEnvoy Medical Inc.

Envoy Medical Inc.

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
6.86 USD -0.09 ( 1.29%)
Last update at 2026-11-12T14:30:00Z
VOLUME
938
Market Cap
54.81M

Momentum Score

…

Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
6.86
Low
6.86
High
52 Week Price Range
0.36
Low
1.89
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Envoy Medical Inc. (COCH.US) is limited; the company has been associated publicly with developing implantable hearing technologies but current disclosures and operations are unclear. Long-term growth drivers for a business of this type include rising prevalence of hearing loss in aging populations, wider adoption of implantable solutions if commercialized, and improvements in reimbursement and distribution, and investors may find upside if disclosure and execution are restored and products reach sustainable market uptake. The most important investment risk is the scarcity of recent public disclosure and unclear financial and operational status, which creates substantial execution, regulatory and commercialization uncertainty.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
6.95
Dividend Yield
-
Revenue TTM
0.21M
Revenue Per Share
0.00
Gross Profit TTM
-0.61M
Debt / Equity
-0.08
ROE
-
Net Debt
-2.82M
ROCE
741.34%
Diluted EPS TTM
-0.74

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -23.76M -20.80M -29.91M -15.92M -8.68M
Net income -23.76M -20.80M -29.91M -15.92M -8.68M
Selling general administrative 7.93M 6.83M 7.28M 3.47M 2.47M
Selling and marketing expenses 1.22M 1.73M 1.67M 0.89M -
Gross profit -0.63M -0.52M -0.61M -0.72M -0.46M
Reconciled depreciation 0.30M 0.17M 0.11M 0.07M 0.07M
Ebit -22.27M -19.98M -18.37M -8.71M -6.87M
Ebitda -21.97M -19.81M -18.24M -8.63M -6.80M
Depreciation and amortization 0.30M 0.17M 0.13M 0.07M 0.07M
Operating income -22.27M -19.26M -18.37M -8.71M -6.87M
Other operating expenses 22.51M 19.48M 18.69M 8.94M 7.18M
Interest expense 1.59M 0.82M - - -
Net interest income -1.59M -0.82M - - -
Total revenue 0.24M 0.23M 0.32M 0.24M 0.31M
Total operating expenses 21.64M 18.74M 17.77M 7.99M 6.41M
Cost of revenue 0.87M 0.74M 0.92M 0.96M 0.77M
Total other income expense net -1.49M -1.54M -11.54M -7.22M -1.80M
Net income from continuing ops -23.76M -20.80M -36.50M -15.92M -8.68M
Net income applicable to common shares - - - -17.92M -10.68M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 8.56M 11.54M 7.64M 2.56M 2.62M
Other current assets 0.96M 1.38M 0.96M 0.13M 0.00M
Total liab 20.32M 30.38M 9.40M 58.72M 47.58M
Total stockholder equity -11.77M -18.84M -1.76M -56.17M -44.96M
Other current liab 8.47M 5.74M 4.92M 0.93M 0.71M
Common stock 0.00M 0.00M 0.00M 1.39M 1.39M
Capital stock 0.00M 0.00M - 1.39M 1.39M
Retained earnings -313.40M -284.73M -257.24M -225.99M -210.06M
Other liab - - - 2.27M 2.75M
Other assets - - 0.00M - -
Cash 3.74M 5.48M 4.22M 0.18M 1.12M
Total current liabilities 11.56M 7.54M 6.64M 2.52M 1.38M
Current deferred revenue - - - 0.01M 0.01M
Net debt -2.82M 14.18M -3.66M 34.35M 22.36M
Short term debt 0.17M 0.14M 0.16M 0.57M 0.46M
Short long term debt - - - 0.45M -
Short long term debt total 0.92M 19.66M 0.56M 34.53M 23.48M
Other stockholder equity 301.75M 266.01M 255.60M 168.54M 163.82M
Property plant equipment - - - 0.91M 0.19M
Total current assets 6.28M 9.38M 6.83M 1.65M 2.44M
Net tangible assets - - - -56.17M -44.96M
Net receivables 0.03M 0.82M 0.25M 0.04M 0.09M
Long term debt - 18.72M - 33.40M 23.48M
Inventory 1.55M 1.71M 1.40M 1.29M 1.06M
Accounts payable 2.92M 1.65M 1.55M 1.00M 0.66M
Accumulated other comprehensive income -0.12M -0.12M -0.12M -0.12M -0.11M
Non currrent assets other 0.36M - -0.00M - -0.43M
Non current assets total 2.28M 2.15M 0.81M 0.91M 0.19M
Capital lease obligations 0.92M 0.94M - 0.69M 0.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -0.98M -0.17M -0.22M -0.12M
Change to liabilities - - - 0.34M 0.23M
Total cashflows from investing activities -0.18M -0.98M - -0.22M -0.12M
Net borrowings 9.17M 19.08M - 8.00M 8.00M
Total cash from financing activities 16.63M 20.20M 21.84M 8.09M 8.06M
Change to operating activities - - - -0.35M -0.34M
Net income -23.76M -22.45M -29.91M -15.92M -8.68M
Change in cash -1.74M 1.26M 4.04M -0.94M 0.99M
Begin period cash flow 5.48M 4.22M 0.18M 1.12M 0.13M
End period cash flow 3.74M 5.48M 4.22M 0.18M 1.12M
Total cash from operating activities -18.20M -17.95M -17.65M -8.80M -6.94M
Issuance of capital stock 7.10M 1.75M - - -
Depreciation 0.30M 0.17M 0.13M 0.07M 0.07M
Dividends paid 1.82M 2.45M - - -
Change to inventory 0.13M -0.38M -0.01M -0.19M 0.06M
Change to account receivables 0.77M -0.57M -0.20M 0.05M -0.02M
Sale purchase of stock 0.18M 0.06M - - -
Other cashflows from financing activities -0.06M 0.90M 11.85M 0.09M 8.06M
Change to netincome - - - 7.20M 1.75M
Capital expenditures 0.18M 0.98M 0.15M 0.22M 0.12M
Change in working capital 1.84M -0.64M -0.96M -0.16M -0.08M
Stock based compensation 0.09M 0.56M 1.57M - -
Other non cash items 3.33M 4.97M 13.01M 7.20M 1.75M
Free cash flow -18.38M -18.93M -17.81M -9.02M -7.06M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
COCH
Envoy Medical Inc.		 -0.09
1.29%		 6.86 - - 264.77 15.32 182.16 -1.35
ABT
Abbott Laboratories		 -0.71
0.65%		 108.58 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 0.28
0.28%		 101.89 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 -2.16
0.68%		 316.63 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 -
-%		 47.31 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Envoy Medical Inc.

Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

4875 White Bear Parkway, White Bear Lake, MN, United States, 55110

877 900 3277

https://www.envoymedical.com

43

Name Title Year Born
Mr. Brent T. Lucas Esq. CEO & Director 1983
Mr. David R. Wells Chief Financial Officer 1962
Mr. Brent T. Lucas Esq. CEO & Director 1982
Mr. Robert M. Potashnick Interim CFO & Principal Accounting Officer 1981
Ms. Karin Simonson VP, General Counsel & Corporate Secretary NA
Mr. Robert M. Potashnick Chief Accounting Officer, VP of Finance, Principal Financial Officer & Principal Accounting Officer 1981

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CJT
CAD 111.15
+12.71%
CLS
CAD 374.20
+8.33%
GRZ
CAD 4.90
+7.46%
CTC-A
CAD 218.05
+6.38%
FEC
CAD 7.42
+5.85%
TF
CAD 4.13
-19.65%
TLO
CAD 5.98
-15.06%
FSZ
CAD 2.45
-14.04%
XNDU
CAD 3.60
-8.86%
ITR
CAD 2.75
-8.50%

Equity Sectors*

  • Basic Materials

    -2.63%

  • Communication Services

    -0.79%

  • Consumer Cyclical

    +0.08%

  • Consumer Defensive

    -0.12%

  • Energy

    +0.52%

  • Financial Services

    -1.15%

  • Healthcare

    -1.74%

  • Industrials

    -0.64%

  • Real Estate

    -0.12%

  • Technology

    -0.51%

  • Utilities

    -0.02%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…